New injection aims to tame stubborn high cholesterol
NCT ID NCT06109831
Summary
This study tested whether adding a new injectable drug called SHR-1918 to standard cholesterol pills could help patients who still have high 'bad' cholesterol (LDL-C) despite taking their regular medication. It involved 335 adults with poorly controlled cholesterol levels. Researchers measured how much the injection lowered cholesterol over 16 weeks compared to a placebo (dummy) injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.